COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Chinese herbal medicine protection and development plan introduced Chinese herbal medicine ushered in "seven industries"
Before the Office of the State Council forwarded the Ministry of Industry and Information Technology, the State Administration of Traditional Chinese Medicine and other departments, "Chinese Herbal Medicine Protection and Development Plan (2015~2020)." According to the status quo of Chinese herbal medicine protection and development, the "Planning" put forward the development goals for 2020. Some experts said that the country has noticed the problems and challenges encountered in the development of Chinese medicine in recent years, and issued a series of policies to promote the development of Chinese medicine. However, it is worth noting that when the relevant policies are continuously introduced, the standards for the cultivation, production, warehousing and logistics of raw materials for Chinese medicine are more urgently needed to be resolved.
The first sword: the protection of wild medicinal resources
Content: The implementation of the fourth national survey of Chinese medicine resources, the construction of a national vital resource dynamic monitoring network, and the construction of a national traditional Chinese medicine germplasm resources protection system.
As early as 1987, the State Council promulgated the first regulation of the protection of Chinese herbal medicine resources in China, the Regulations on the Protection and Management of Wild Medicinal Materials Resources. For decades, the status of traditional medicine, especially the status and form of Chinese medicine resources, has changed a lot. Industrial development, changes in the ecological environment and human lifestyle have led to major changes in the medical model. The consumption trend of pharmaceutical products is developing in the direction of high efficiency, low toxicity and naturalness. Faced with the gradual expansion of the Chinese herbal medicine market, the sustainable use of wild Chinese herbal medicine, the raw material of traditional Chinese medicine, faces unprecedented challenges. Although relevant departments in China have been promoting the protection of wild Chinese herbal medicine resources, under the new situation, it is still unable to meet the sustainable development needs of wild Chinese
Wang Liming, chief engineer of the Ministry of Industry and Information Technology, said that at present, China's traditional Chinese medicine production technology has been continuously improved, more than 50 kinds of endangered wild Chinese herbal medicines have been planted and farmed or replaced, and more than 200 kinds of commonly used large Chinese herbal medicines have achieved large-scale cultivation and cultivation. However, due to the reduction of land resources and the deterioration of the ecological environment, the loss and exhaustion of some wild Chinese herbal medicine resources and the rescue of endangered Chinese herbal medicines have become a top priority.
However, in recent years, although the country has banned the illegal collection of some rare and endangered wild medicinal materials, many non-collectors are still driven by the interests of the plundering type of mining and cutting, which seriously destroys the wild. Sustainable use of medicinal resources. The promulgation of the "Planning" not only perfected the "Regulations on the Protection and Management of Wild Medicinal Materials", but also raised certain warnings about the current unsatisfactory law enforcement.
The "Plan" clarifies some actions for the Chinese herbal medicine market in the future, such as the establishment of the national Chinese medicine resources and the dynamic network monitoring system. These actions are undoubtedly far-reaching for the production protection of raw materials in the Chinese herbal medicine market in the future.
In China, wild medicinal materials should be protected mainly. In some varieties that cannot be artificially planted, strict control and management should be given to their collection, hunting, acquisition and transportation. In practice, activities that acquire wild medicinal resources for academic and commercial purposes should be distinguished and rationally utilized in the context of ensuring resource conservation.
The second sword: the implementation of high-quality Chinese herbal medicine production engineering
Content: Construction of an endangered and scarce Chinese herbal medicine planting and breeding base, a large-scale high-quality Chinese herbal medicine production base, a breeding base for Chinese herbal medicines, and the development of Chinese medicine production area economy.
In recent years, the development of Chinese herbal medicines in China has been very rapid, but as the market cakes are getting bigger and bigger, the barriers to entry have not improved. For some companies that pursue the interests first, quality has become theirs. The selection of this drug directly led to a serious decline in the quality of artificially planted Chinese herbal medicines in recent years, which has tarnished the development of the entire industry.
Wei Jianhe, deputy director of the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences, said that the "plan" put forward the concept of "base-based" and encouraged powerful production enterprises to build their own planting bases to ensure the quality of medicinal materials. Baseization includes scale, standardization, and industrialization. Of course, it does not exclude retail cultivation. Several retail investors can be organized by enterprises to conduct technical guidance and meet the requirements of standardized operations.
"The base of Chinese herbal medicines is the fundamental solution to achieve resource conservation and sustainable development," said the person in charge of Shengshibai Herbal Medicine Co., Ltd. As a company dominated by the cultivation and processing of Chinese herbal medicines, its Chinese herbal medicines are among the best in terms of exports. “We have established a standardized planting base with a total area of more than 35,000 mu in the main local medicinal materials production areas. We are also working with the Institute of Chinese Medicine of China Academy of Chinese Medical Sciences to study the techniques of farmland ginseng and ginseng continuous cropping to crack the production of ginseng ginseng. the way."
In recent years, local Chinese medicine companies have gradually recognized the importance of resources to the industry and explored the sustainable development of Chinese medicine resources. Leading enterprises such as Tasly, Yunnan Baiyao and Buchang Pharmaceutical have increased the construction of GAP bases, and the core raw materials of some production enterprises have basically achieved base. Some enterprises have also integrated Chinese herbal medicine into environmental management. Yili Group has planted licorice and other Chinese herbal medicines in the desert. On the one hand, it has solved the problem of using medicinal materials. On the other hand, licorice has played an important role in ecological restoration. Got it.
"Chinese herbal medicines are not isolated industries. In order to implement the planning objectives, the entire industrial chain must be considered comprehensively. Only by formulating policies on a certain link, the effect will not be too good." The World Federation of Chinese Medicine Societies Chinese Medicine Pharmaceutical Professional Committee Chang Zhang naturally pointed out that the rules introduced after the hope can take into account the industrial chain, so that the entire industrial chain can be seamlessly connected without any fault.
Some experts believe that the implementation of the "plan" should further increase investment in science and technology, focus on solving the problem of cultivation and breeding of scarce and endangered wild Chinese herbal medicines, and comprehensively improve the high-yield, stable production and high-quality production techniques of large-scale Chinese herbal medicines. At the policy level, upstream enterprises should also be encouraged to build their own medicinal materials production bases, improve relevant systems and strengthen supervision. Accelerate the cultivation of talents, guarantee the transformation of scientific and technological achievements and the promotion of production technology.
The third sword: Chinese herbal medicine technology needs innovation
Content: Strengthen the basic research of Chinese herbal medicines, inherit the innovative traditional Chinese herbal medicine production technology, break through the endangered and scarce Chinese herbal medicine breeding technology, develop the modern production technology of Chinese herbal medicines, and strengthen the comprehensive development and utilization of Chinese herbal medicines.
The Chinese medicine industry is a high-tech industry. Although Chinese medicine has a long history in China, in the past few years, it has met the needs of the Chinese people for medical care, expanded the export of famous Chinese medicines, and prevented and resisted the impact of Western medicine on Chinese traditional Chinese medicine after entering the WTO. China also has many promotion policies for the development of Chinese medicine.
According to statistics, with the vigorous development of Chinese medicine industry and the continuous development of new varieties of traditional Chinese medicine, the demand for Chinese herbal medicines is increasing at a rate of more than 10% per year. Among them, especially the Chinese herbal medicines produced by standardized operation and no pollution The Chinese herbal medicines are selling better in the international and domestic markets. After joining the WTO, although China's agriculture has been greatly affected, it has gained more opportunities as a medicinal plant with Chinese characteristics. Some enterprises have seized it, and some enterprises with limited technology can only be submerged in the torrent of history. in.
The release of the "Planning" proposes to strengthen the basic research of Chinese herbal medicines and develop modern production techniques of Chinese herbal medicines, and at the same time break through the breeding of endangered and scarce Chinese herbal medicines, aiming to improve the competitiveness of Chinese traditional Chinese herbal medicines in the market.
Some experts said that China's Chinese herbal medicine technology innovation must focus on the screening of new varieties of high-quality Chinese herbal medicines and research on high-yield, high-quality, pollution-free cultivation techniques, promoting the commercialization of new technologies and new products of Chinese herbal medicines, and at the same time, for Chinese medicines. The continuous and rapid development of materials provides mature supporting new technologies, gathers, trains and trains high-level Chinese herbal medicine technology and management talents, and carries out international technical cooperation and exchanges. Only in this way can the “innovation” proposed in the “Planning” Really put into reality.
The fourth sword: Chinese herbal medicine organization innovation
Content: Cultivate modern Chinese herbal medicine production enterprises, promote the joint construction and sharing of Chinese herbal medicine bases, and improve the organizational level of Chinese herbal medicine production.
The 21st century is an era of economic globalization. In recent years, the Chinese traditional Chinese medicine industry has faced competition from various foreign drugs, including Western medicine, but at the same time, it has more room for development. In China's traditional Chinese medicine industry, because it can not fully meet the requirements of the international pharmaceutical market, the advantages of traditional medicine products in Asian countries such as Japan, South Korea and other countries are not very obvious. On this basis, we want to improve our competitiveness. Chinese traditional Chinese medicine enterprises must constantly innovate in the competition to be invincible.
Enterprise organization is the carrier to help managers achieve their strategic goals. Traditional Chinese medicine enterprises should create an environment from organizational structure and mechanism, so that their own innovation strategies can be implemented smoothly. From the well-known successful experience of strategic development of enterprises, the sharing of bases mentioned in the “Planning” and the improvement of the level of production organization are necessary.
Relevant experts said that the establishment of Chinese medicine enterprises must be market-oriented. In terms of organizational form, it is necessary to realize the separation of government and enterprise, and to form a reasonable and efficient management mode among colleagues in ensuring product quality. At the same time, to promote the sharing of Chinese herbal medicine bases must optimize the allocation of resources in order to fundamentally improve the market competitiveness of enterprises. Organizational innovation is to serve technological innovation. At present, with the characteristics and overall level of China's traditional Chinese medicine industry, cooperation and innovation of Chinese medicine enterprises is the real mainstream, supplemented by imitation and innovation. Only when the company develops, the overall industry will develop healthily.
The fifth sword: building a quality assurance system for Chinese herbal medicines
Content: Improve and improve the standards of Chinese herbal medicines, improve the quality management regulations for the production and management of Chinese herbal medicines, and the quality inspection and testing system for Chinese herbal medicines, and establish a full-process traceability system covering the main varieties of Chinese herbal medicines.
Improving the whole process quality traceability system of Chinese herbal medicines is conducive to eliminating the phenomenon of counterfeiting and selling fakes in the supply and marketing of Chinese herbal medicines. Yan Xijun, Chairman of the Board of Directors of Tasly Holding Group, said in an interview with the media that China has positioned Chinese herbal medicines as agricultural and sideline products. The relevant national laws and regulations have not established a clear distinction between the processing of Chinese herbal medicines and the processing of Chinese herbal medicines. The merchants of medicines are in the name of the initial processing of medicines. The production and operation of traditional Chinese medicine decoction pieces has led to various chaos of Chinese medicine decoction pieces. In addition, the logistics process after the collection of medicinal materials is very complicated. The medicinal materials are purchased, packaged, stored and transported by multi-level purchasers. Mixed batches, mixed bags, mixed storage and other phenomena are very common. The sources of medicinal materials are mixed, and the fake materials are filled with Filling up violations of laws and regulations is a common "hard injury" in the circulation of Chinese herbal medicines. Moreover, the market for the decoction piece market is not subject to grades and grades, causing some medical units to purchase the pieces only to see the price and not to see the quality. The low threshold has become one of the factors restricting the development of the industry.
Yan Xijun said that the national policy clearly proposes to build a traceability system for the circulation of Chinese herbal medicines, but it also faces some practical difficulties, such as complex production areas to pharmacies, low enthusiasm for SMEs, lack of access standards and strict supervision. Once you are done, you need the support and encouragement of a series of policies and the coordination of relevant departments. He suggested that it is necessary to accelerate the construction of quality information in the traceability system of Chinese herbal medicines, and introduce relevant policies to encourage the introduction of qualified third-party inspection service agencies, which can increase the quality information in the traceable two-dimensional code of each link and realize the dynamics of quality information. Passing, truly "source can be known, can be traced, quality can be checked, responsibility can be studied." It is also necessary to speed up the construction and operation and maintenance of Chinese herbal medicine traceability system, introduce market entities to achieve independent operation, and strengthen the policy supervision of Chinese herbal medicines and decoction pieces.
In China's Chinese herbal medicine industry, quality is still a prerequisite for all. Competitiveness depends on quality, profit on quality, and word of mouth on quality. What should be done is to strengthen the management of integrity, implement rewards and punishments, and adopt different regulatory measures for enterprises with different levels of integrity. For enterprises with high levels of integrity, they can avoid tracking inspection, renewal inspection or reduce tracking inspection. Frequency, etc. For enterprises with poor integrity, it is necessary to increase the frequency of flight inspections and daily supervision and inspection. At the same time, the bad behaviors of the main employees of pharmaceutical production enterprises are recorded and publicized.
The Sixth Sword: Building a Chinese Medicine Production Service System
Content: Construction of production technology service network and production information service platform to strengthen the supply of Chinese herbal medicines.
Professor Wang Wenquan from the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences said that China's traditional Chinese medicine industry has basically formed a systematic industrial system based on the production of Chinese herbal medicines, relying on modern science and technology, industry as the mainstay, business as the link, and pharmaceutical consumption as the terminal. The scale of artificial production of Chinese herbal medicines is expanding day by day. More than 200 of the more than 600 kinds of commonly used Chinese herbal medicines have been artificially mass-produced. The planting area of the country is more than 20 million mu (including wild tending), of which more than 1 million mu of standardized planting bases are used. The annual output is more than 2.5 million tons, and the artificial planting yield of Chinese herbal medicines accounts for more than 70% of the total supply; the development of rare and endangered biological medicinal materials and the development of alternatives have been greatly developed. Musk, bear bile, bezoar, snakes and other varieties are widely distributed. The production pattern of Chinese herbal medicines with remarkable characteristics has basically taken shape.
In recent years, the construction of the Chinese herbal medicine production service system has attracted the attention of experts from all sides. The drug market has a common saying: "Businessmen are not as good as business, and business is not as good as business." Under the background of the traditional trade mode characterized by “trading and business”, the “strategy management” method of hoarding speculation as a means of profit will intensify. Coupled with the strong involvement of large enterprises and external hot money, the supply of raw materials for Chinese herbal medicines will face severe challenges. On the one hand, this kind of format will force pharmaceutical companies to go to the source of production, to ensure the supply of raw materials by means of production and marketing docking and production bases; on the other hand, it will maintain the relatively high price of raw materials for Chinese herbal medicines, and will not fall into the "big" again. The history of the big down. At the same time, the importance of traditional Chinese medicine raw materials is increasingly prominent, and the strong desire of capital to intervene in the industry will stimulate the knowledgeable enterprises to open up the entire industrial chain of the Chinese medicine industry. The use of modern e-commerce platforms, financing platforms and other means to fully integrate and structure resources, finance, and finished product sales, and ultimately create an "aircraft carrier" for the Chinese medicine industry. Therefore, the era of great health is experiencing explosive growth, and the Chinese medicine industry has also ushered in unprecedented development opportunities.
The construction of production technology service network and production information service platform mentioned in the "Planning" to strengthen the supply of Chinese herbal medicines is a long-term plan for the future Chinese herbal medicine market. Only when the supply is guaranteed can it adapt to the increasing demand. The demand of the terminal market only guarantees the construction of the information service network, and there will be no information asymmetry.
The Seventh Sword: Constructing a Modern Circulation System of Chinese Medicinal Materials
Content: Improve the standard of Chinese herbal medicine circulation industry and build a modern logistics system for Chinese herbal medicines.
The total amount of Chinese herbal medicines in China is about 17 million tons per year. Since the reform and opening up, China's Chinese herbal medicine logistics system has made certain progress. However, with the development of China's economy and society, the contradiction between the Chinese herbal medicine logistics system not adapting to the development of Chinese medicine and the expansion of the people's health needs has become more prominent, promoting the construction of modern logistics system of Chinese herbal medicines, and improving the organization and modernization level of Chinese herbal medicine circulation. It is of great significance to enhance the circulation of Chinese herbal medicines to the quality and safety of Chinese herbal medicines and to promote the sustainable and healthy development of Chinese medicine.
The promulgation of the "Planning" reflects the country's insistence on serving the people's health, in order to improve the intensive modernization level of Chinese herbal medicine logistics.